BostonSight’s PROSE treatment linked to Mackie stage, VA gains in NK

BostonSight Initiates Trial Examining Mental Health Outcomes with PROSE Treatment and Scleral Lenses

BostonSight and LV Prasad Eye Institute Announce Study on the Effect of PROSE and SCLERAL Lenses on Mental Health

NEEDHAM, MA, UNITED STATES BostonSight® announced today they have initiated a prospective clinical trial to evaluate the effect that PROSE® treatment and scleral lenses may have...

PROSE Shows Improvements in NK Stage and Visual Acuity

Current Scleral Lens Solution Shortages and Alternatives

updated August 3, 2026 Recalls For a complete list from the FDA, please read here. AvKare Eye Drops; Read here. Nutrifill...

Ophthalmologists Are Begging People To Throw Out This Common Item

BostonSight Announces Key Findings in Using PROSE for the Treatment of Neurotrophic Keratitis

Overall, results demonstrated a statistically significant improvement in Mackie Stage (mean) and Visual Acuity (mean) after PROSE treatment among eyes with...

BostonSight Explores Drug-Delivery Use of Scleral Lenses

BostonSight manufactures two scleral lenses, the PROSE device and BostonSight SCLERAL lens, that have been used for decades to treat dry...

Eye Drop Recall Notice June 2026